Stockscreener 앱 받기
1.86
38.00%
-1.14
시간 외 거래:
1.92
0.06
+3.23%
전일 마감가:
$3.00
열려 있는:
$2.55
하루 거래량:
6.41M
Relative Volume:
34.22
시가총액:
$1.31M
수익:
-
순이익/손실:
$-9.60M
주가수익비율:
-0.5886
EPS:
-3.16
순현금흐름:
$-8.96M
1주 성능:
-47.61%
1개월 성능:
-60.34%
6개월 성능:
-69.61%
1년 성능:
-72.80%
1일 변동 폭
$1.8401
$2.5999
1주일 범위
$1.8401
$3.68
52주 변동 폭
$1.8401
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
명칭
Artelo Biosciences Inc
전화
858-925-7049
주소
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
ARTL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
1.86 | 5.99M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-08 | 업그레이드 | D. Boral Capital | Hold → Buy |
| 2021-02-12 | 개시 | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc 주식(ARTL)의 최신 뉴스
Artelo Biosciences (ARTL) Publishes Key Research on Cancer and F - GuruFocus
Artelo Biosciences Publishes Article on FABP3's Role in Cancer in Drug Discovery Today - Quiver Quantitative
Artelo Bio (Nasdaq: ARTL) highlights FABP3 in cancer in Drug Discovery Today review - Stock Titan
Analyzing recovery setups for Artelo Biosciences Inc. investorsJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com
Measuring Artelo Biosciences Inc.’s beta against major indicesJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Is Artelo Biosciences Inc. building a consolidation baseTrade Volume Report & Weekly High Potential Stock Alerts - newser.com
How to use Fibonacci retracement on Artelo Biosciences Inc.July 2025 Macro Moves & Safe Entry Momentum Tips - newser.com
Will Artelo Biosciences Inc. outperform the marketJuly 2025 Closing Moves & Reliable Breakout Forecasts - newser.com
Regression analysis insights on Artelo Biosciences Inc. performanceCEO Change & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-11-03 21:09:41 - newser.com
What is the fair value of Artelo Biosciences Inc. stock now2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com
What momentum shifts mean for Artelo Biosciences Inc.July 2025 Earnings & Smart Money Movement Alerts - newser.com
Artelo Biosciences Inc. stock trend forecastShort Setup & Daily Volume Surge Trade Alerts - newser.com
Will Artelo Biosciences Inc. stock benefit from infrastructure spendingIndex Update & Proven Capital Preservation Methods - newser.com
Earnings visualization tools for Artelo Biosciences Inc.July 2025 Volume & Free Community Supported Trade Ideas - newser.com
Is Artelo Biosciences Inc. stock entering bullish territoryTrade Analysis Summary & Real-Time Market Sentiment Alerts - newser.com
Will Artelo Biosciences Inc. see short term momentumTrade Analysis Report & Verified Swing Trading Watchlists - newser.com
Published on: 2025-11-03 06:38:06 - earlytimes.in
What analysts say about BloomZ Inc stockFundamental Stock Analysis & Low Cost Trading Ideas - earlytimes.in
Artelo Biosciences Inc Stock Analysis and ForecastOptions Trading Strategies & 100% Free Stock Analysis for Smarter Decisions - earlytimes.in
Artelo Biosciences Strengthens Financial Position with New Agreement - The Globe and Mail
Is Artelo Biosciences Inc. stock gaining market shareMarket Performance Summary & Verified Momentum Stock Alerts - newser.com
[8-K] ARTELO BIOSCIENCES, INC. Reports Material Event | ARTL SEC FilingForm 8-K - Stock Titan
Is Artelo Biosciences Inc. stock near bottom after declinePortfolio Update Report & Verified Momentum Stock Alerts - newser.com
[Form 4] ARTELO BIOSCIENCES, INC. Insider Trading Activity - Stock Titan
704,425 Common Stock of Artelo Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2025. - MarketScreener
Artelo Biosciences Inc (ARTL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):